The inhibitory effect on TNF-α and IL-6 production by magnolol may contribute to the bone antiresorbing effect of magnolol and possibly also play a role in the reduction of bone loss seen in the vicinity of inflammatory processes such as rheumatoid arthritis and periodontal disease. This evidence concerns the gene TNF and rheumatoid arthritis.